August 12, 2024 – On August 7, 2024, Globe Life published its 10-Q for Q2 2024 which contains several damning admissions about the company’s conduct and unexplained changes in disclosure.
- Globe Life management misled analysts and shareholders about the existence of an SEC investigation
- In its Q2 2024 10-Q, Globe Life finally disclosed that it received the first inquiry of the SEC investigation in April 2024, at least 2 weeks before management told JP Morgan it was not under investigation.
- The inquiries made by the SEC are no longer described as “informal, preliminary”, and the company is apparently subject to a formal investigation.
- Our analysis of Globe Life’s disclosures suggests the SEC has made at least 2 inquiries with the company.
- The 10-Q also contains multiple other changes in disclosure, despite the company claiming that the recently-completed independent investigation by Wilmer Hale and FTI Consulting found no fault in its reporting.
- No explanation is given for these changes.
- The company included a legal case last mentioned in its Q2 2022 10-Q, despite the last major event in the case occurring in Q1 2023.
- The company has changed the language around its performance metrics: net sales and first year collected premium.
- Globe Life spent over 85% of the $370mm high end of its buyback program guidance for 2024 in just two months.
- Globe Life drew a total of $345m in liquidity from their FHLB funding; regardless of the original purpose for this liquidity draw, it was effectively used to finance the buyback.